IQVIA Holdings Inc.

IQV ·Healthcare, Diagnostics & Research, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $9.74B $6.88B $5.74B $5.46B $5.10B $4.87B $4.33B
Cost of Revenue $6.30B $3.24B $2.71B $2.66B $2.47B $2.46B $2.15B
Gross Profit $3.44B $3.64B $3.03B $2.80B $2.63B $2.41B $2.17B
Gross Margin 35.3% 53.0% 52.8% 51.2% 51.5% 49.5% 50.3%
Operating Expenses
Research & Development — — $3.3M $5.8M $5.0M $10.4M $10.0M
SG&A Expense $1.62B $1.02B $815.0M $781.0M $860.5M $817.8M $762.3M
Operating Income $665.0M $576.0M $646.0M $590.0M $462.3M $396.4M $345.3M
Operating Margin 6.8% 8.4% 11.3% 10.8% 9.1% 8.1% 8.0%
Interest Expense $346.0M $144.0M $101.0M $101.0M $123.5M $-134.4M $109.1M
Pretax Income $294.0M $416.0M $539.0M $501.0M $323.1M $267.4M $184.7M
Income Tax Expense $-992.0M $325.0M $159.0M $149.0M $96.0M $93.4M $15.1M
Net Income $1.28B $72.0M $387.0M $357.0M $226.6M $177.5M $241.8M
Net Margin 13.1% 1.0% 6.7% 6.5% 4.4% 3.6% 5.6%
EPS (Basic) $5.86 $0.48 $3.15 $2.78 $1.83 $1.53 $2.08
EPS (Diluted) $5.74 $0.47 $3.08 $2.72 $1.77 $1.51 $2.05
Shares Outstanding (Basic) 217.8M 149.1M 123.0M 128.0M 124.1M 115.7M 116.2M
Shares Outstanding (Diluted) 222.6M 152.0M 125.6M 131.1M 127.9M 117.8M 117.9M
Dividends Per Share — — — — — — —
← Newer Page 2 of 2 Older →